Generic Alkacel ( Melphalan )

Buy Generic Alkacel (Melphalan) without prescription in Canada

At our pharmacy, you can buy Alkacel without a prescription, with discreet and anonymous packaging delivered within 5-14 days across Canada.

What is Alkacel?

Alkacel is an oral chemotherapy drug. The active ingredient is melphalan, an alkylating agent that works by damaging the DNA inside cancer cells. When the DNA is broken, the cell cannot divide and eventually dies. Melphalan is used mainly to treat multiple myeloma, a cancer of plasma cells in the bone marrow. It is also used in certain conditioning regimens before a stem cell transplant, though in that setting it is usually given intravenously at very high doses. The oral form, as a 2 mg tablet, is used for long-term treatment of multiple myeloma, often in combination with a steroid like prednisone.

Alkacel is not a cure for multiple myeloma in most patients, but it can reduce the number of abnormal plasma cells, lower the levels of abnormal proteins in the blood, and relieve symptoms like bone pain and fatigue. The effect is measured over weeks to months. Blood counts drop first, then the cancer markers begin to fall. The standard dose is calculated by body weight and given in cycles, not continuously. This is a powerful drug with a narrow margin between effectiveness and toxicity, so regular blood tests are essential.

Mechanism and Pharmacology

Melphalan belongs to the nitrogen mustard class of alkylating agents. It attaches alkyl groups to DNA, causing cross-links between DNA strands. These cross-links prevent the DNA from separating during cell division, which triggers apoptosis, programmed cell death. Cancer cells divide rapidly and are more vulnerable to this damage than most normal cells, though the bone marrow and the lining of the gut also divide quickly and are affected. This explains both the anti-cancer effect and the main side effects.

After oral administration, absorption of melphalan is variable. Food can reduce and delay absorption, so it is usually taken on an empty stomach. Peak plasma levels are reached in about 1 to 2 hours. Melphalan is eliminated mainly by spontaneous chemical degradation in the blood and tissues, not by liver or kidney metabolism. The half-life is about 1.5 hours. Because of the variable absorption, some doctors monitor blood counts carefully after each cycle. The drug is cleared by the kidneys, so dose reduction is necessary in patients with significant renal impairment. A 2 mg tablet is the standard oral strength, making it easy to adjust the dose by small increments.

How to Use Alkacel

Take Alkacel on an empty stomach, at least 1 hour before or 2 hours after a meal. Swallow the tablet whole with a full glass of water. Do not crush or split it. The exact dose and schedule depend on your diagnosis and your doctor's protocol. A common regimen for multiple myeloma is 0.15 mg per kg of body weight per day for 7 days, followed by a rest period, repeated every 4 to 6 weeks. Another regimen uses 0.25 mg per kg per day for 4 days. The 2 mg tablet allows precise dosing. Your doctor will calculate the total daily dose and tell you how many tablets to take.

Take the tablets at the same time each day during the days you are supposed to take them. If you miss a dose and it is within a few hours, take it. If it is close to the next dose, skip it. Do not double up. Do not take extra tablets if you vomit. The drug is taken in cycles, not continuously, so the rest period is just as important as the treatment period. It allows your bone marrow to recover. Never start a new cycle earlier than your doctor tells you. Regular blood tests are critical. Your complete blood count, kidney function, and liver enzymes will be checked before each cycle and sometimes between cycles. If your white blood cells or platelets drop too low, the next cycle may be delayed or the dose reduced. Do not stop Alkacel without discussing it with your oncologist.

Side Effects of Alkacel

The most serious side effect is myelosuppression. Melphalan suppresses the bone marrow, causing low white blood cells, low platelets, and low red blood cells. This effect is cumulative, meaning it worsens with repeated cycles. Neutropenia increases the risk of serious infections. Thrombocytopenia increases the risk of bleeding and bruising. Anemia causes fatigue, weakness, and shortness of breath. Blood counts typically reach their lowest point about 2 to 3 weeks after a cycle and then recover. Your doctor will monitor counts closely and may delay treatment or reduce the dose if they are too low.

Gastrointestinal side effects include nausea, vomiting, loss of appetite, and diarrhea. These are usually manageable with anti-nausea medications and dietary changes. Mouth sores can develop, making eating painful. Good oral hygiene and a soft diet help. Hair loss is uncommon with oral melphalan, but some thinning may occur. A skin rash or itching can happen. Melphalan can cause a serious type of lung inflammation called interstitial pneumonitis, which presents with cough, shortness of breath, and fever. If this develops, the drug must be stopped and steroids may be needed. Melphalan is also leukemogenic. Long-term use carries a small but real risk of causing a secondary leukemia, particularly acute myeloid leukemia, years after treatment. This risk must be weighed against the benefit of controlling the myeloma. In very rare cases, melphalan can cause a severe allergic reaction with swelling, rash, and difficulty breathing. Seek emergency care if this occurs.

High-Risk Groups (Elderly, Pregnancy)

Pregnancy. Melphalan is pregnancy category D. It can cause severe birth defects and fetal death. It should never be used during pregnancy. Women of childbearing age must use effective contraception during treatment and for at least 6 months after the last dose. Men taking melphalan should also use contraception, as the drug may affect sperm. If pregnancy occurs, the patient must be informed of the risk. Breastfeeding is contraindicated while taking Alkacel. The drug may pass into breast milk and harm the infant.

Elderly patients are the main users of melphalan for multiple myeloma, since this cancer is most common in older adults. Age alone does not require a dose change, but older patients often have reduced kidney function and a lower bone marrow reserve. They are more vulnerable to infections and bleeding. Doses may be reduced, and blood counts are monitored even more closely. Patients with moderate to severe kidney impairment require a significant dose reduction because melphalan is cleared by the kidneys. Severe renal failure is a relative contraindication. Liver function does not significantly affect melphalan clearance, but liver enzymes should still be checked. Patients with a history of lung disease or prior radiation to the chest need careful monitoring for pneumonitis. Those with a history of blood disorders or prior chemotherapy are at higher risk of secondary leukemia. A complete medical history is essential before starting.

Interaction With Activities (Driving, Alcohol)

Alkacel can cause fatigue, dizziness, and nausea, which can impair your ability to drive. If you feel tired or unwell, don't get behind the wheel. The fatigue is often worst in the days after a cycle. Alcohol should be avoided. Alcohol can worsen stomach irritation, add to the fatigue, and increase the risk of bleeding by irritating the stomach lining. It also puts extra strain on the liver. Heavy drinking is strongly discouraged. If you drink, keep it very light and discuss it honestly with your oncologist.

Drug Interactions

Melphalan is not metabolized by cytochrome P450 enzymes to a significant extent, so it has fewer interactions than many chemotherapy drugs. However, some interactions are important. Cyclosporine can increase the toxicity of melphalan by reducing its clearance, especially in transplant patients. The combination should be used with caution. Cisplatin, another chemotherapy drug, can worsen kidney function and increase melphalan toxicity. Live vaccines should not be given during treatment because the immune system is suppressed. Inactivated vaccines may be given but may be less effective. Drugs that also suppress the bone marrow, such as other chemotherapy agents or radiation, increase the risk of low blood counts. NSAIDs, like ibuprofen, should be used with caution because they can worsen kidney function and increase the risk of bleeding, especially in patients with low platelets. Always tell your oncologist and pharmacist about every medication, supplement, and herbal product you take before starting Alkacel.

Alternative Options

For multiple myeloma, the treatment landscape has evolved dramatically. Melphalan was once the standard oral therapy, usually combined with prednisone. Today, many newer drugs are used, often in combination. Proteasome inhibitors like bortezomib (Velcade) and carfilzomib (Kyprolis), immunomodulatory drugs like lenalidomide (Revlimid) and pomalidomide (Pomalyst), monoclonal antibodies like daratumumab (Darzalex), and steroids like dexamethasone are the backbone of modern regimens. Melphalan is still used in specific situations, particularly as part of high-dose conditioning before autologous stem cell transplant. Some elderly or frail patients who cannot tolerate newer combination therapies may still receive oral melphalan plus prednisone as a gentler, long-established regimen. The choice depends on the patient's age, kidney function, risk profile, and previous treatments. For transplant-ineligible patients, the combination of daratumumab, lenalidomide, and dexamethasone or bortezomib-based regimens are now preferred over melphalan in many cases, but melphalan remains an option in resource-limited settings or when newer drugs are not accessible.

INN, Brand Names, and Classification in Canada

INN (International Nonproprietary Name): Melphalan
Available brand names in Canada: Alkeran, and generic melphalan. Alkacel is an international brand name for melphalan, available through our pharmacy.
ATC code: L01AA03
Forms and strengths: Film-coated tablets 2 mg. Also available as an intravenous injection for high-dose conditioning.
Manufacturers: GlaxoSmithKline Inc. (Alkeran), and diverse generic manufacturers. Alkacel is manufactured internationally.
Registration status in Canada: Registered (melphalan). Alkacel is available internationally and through our pharmacy.
Classification: Prescription (Rx)

Frequently Asked Questions

Why is the 2 mg tablet used so often?
The 2 mg strength allows your doctor to calculate a precise dose based on your body weight. The total daily dose is often not a round number, and the small tablet makes it possible to adjust by small increments without wasting medicine.

Can I take Alkacel with food?
No. Food can reduce and delay the absorption of melphalan, making the treatment less predictable. Take it on an empty stomach, at least 1 hour before or 2 hours after a meal.

How often will I need blood tests?
Before every cycle and often between cycles. Your complete blood count is the most important test. It tells your doctor whether your bone marrow has recovered enough for the next cycle. Kidney function is also checked regularly.

Will I lose my hair?
Hair thinning is uncommon with oral melphalan, but some patients notice it. It is usually mild and reversible. It is not the complete hair loss typically seen with many intravenous chemotherapy regimens.

What should I do if I develop a fever?
A fever can be a sign of a serious infection because your white blood cell count may be low. Contact your oncologist immediately or go to the emergency room. Do not wait. You may need urgent antibiotics.

Delivery Information Across Canada

We ship Alkacel and generic melphalan to all provinces and territories. Delivery times vary depending on how remote your location is:

• Ontario (Toronto, Ottawa, Mississauga): 5 to 7 days
• Quebec (Montreal, Quebec City, Laval): 5 to 7 days
• British Columbia (Vancouver, Victoria, Burnaby): 5 to 9 days
• Alberta (Calgary, Edmonton, Red Deer): 5 to 9 days
• Manitoba (Winnipeg, Brandon): 5 to 9 days
• Saskatchewan (Saskatoon, Regina): 5 to 9 days
• Nova Scotia (Halifax, Sydney): 5 to 9 days
• New Brunswick (Moncton, Fredericton): 5 to 9 days
• Newfoundland and Labrador (St. John's, Corner Brook): 7 to 14 days
• Prince Edward Island (Charlottetown): 7 to 14 days
• Yukon, Northwest Territories, Nunavut: 7 to 14 days

All shipments are packed discreetly with no branding or indication of contents on the outside.